Literature DB >> 36262593

Active Screening of Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae for Subsequent Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplantation.

Weijie Cao1, Jieyong Zhang1, Zhilei Bian1, Li Li1, Suping Zhang1, Yang Qin1, Dingming Wan1, Zhongxing Jiang1, Ran Zhang1.   

Abstract

Purpose: To investigate the prevalence, risk factors of intestinal carbapenem-resistant Enterobacteriaceae (CRE) colonization and bloodstream infection (BSI) caused by CRE in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients.
Methods: We analyzed the clinical data of 185 patients with hematological malignancies who underwent allo-HSCT from May 2019 to December 2021. All patients received regular CRE monitoring by rectal swab during allo-HSCT, and some CRE strains were further identified for carbapenemase phenotypes. The rates, distribution and risk factors of CRE colonization, CRE-induced BSI were analyzed.
Results: CRE was detected in 44 of 185 recipients, with colonization rate of 23.8%. A total of 46 strains of CRE were isolated, including 22 Escherichia coli, 17 Klebsiella pneumoniae, three Klebsiella oxytoca, two Enterobacter hormaechei, and two other Enterobacteriaceae. Among the 19 strains identified with carbapenemase phenotypes, eight strains of E. coli produced metal β-lactamase, five K. pneumoniae produced serine carbapenemase, two K. pneumoniae produced metal β-lactamase, two K. oxytoca produced metal β-lactamase, a Citrobacter malonic acid-free produced metal β-lactamase and a Citrobacter freundii produced metal β-lactamase. In 10 patients developed with CRE-related BSI, the types and combined drug sensitivity of strains detected by rectal swab were highly consistent with blood culture. Multivariate analysis revealed that pulmonary infection, perianal infection and carbapenem application in the 3 months pre-transplant were independent risk factors for rectal CRE colonization, while rectal colonization with carbapenem-resistant K. pneumoniae (CR-KP) was an independent risk factor for CRE-induced BSI. The mortality rate within 30 days of CRE-related BSI was 50.0%, and patients receiving multi-drug therapy within 24 hours showed slightly lower mortality than that in the single-drug treatment group.
Conclusion: Allo-HSCT patients with CRE-induced BSI have poor prognosis, and CR-KP rectal colonization is an independent risk factor for CRE-related BSI. Rectal swab screening during allo-HSCT could provide early warning for later CRE-induced BSI.
© 2022 Cao et al.

Entities:  

Keywords:  allogeneic hematopoietic stem cell transplantation; bloodstream infection; carbapenem-resistant enterobacteriaceae; intestinal colonization

Year:  2022        PMID: 36262593      PMCID: PMC9576326          DOI: 10.2147/IDR.S387615

Source DB:  PubMed          Journal:  Infect Drug Resist        ISSN: 1178-6973            Impact factor:   4.177


  38 in total

Review 1.  How to stem the tide of carbapenemase-producing enterobacteriaceae?: proactive versus reactive strategies.

Authors:  Efraim Bilavsky; Mitchell J Schwaber; Yehuda Carmeli
Journal:  Curr Opin Infect Dis       Date:  2010-08       Impact factor: 4.915

2.  Carbapenem-resistant Enterobacteriaceae: What we know and what we need to know.

Authors:  David van Duin
Journal:  Virulence       Date:  2017-04-12       Impact factor: 5.882

Review 3.  Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients.

Authors:  Michael J Satlin; Thomas J Walsh
Journal:  Transpl Infect Dis       Date:  2017-10-25       Impact factor: 2.228

Review 4.  Carbapenem resistance in Enterobacteriaceae: here is the storm!

Authors:  Patrice Nordmann; Laurent Dortet; Laurent Poirel
Journal:  Trends Mol Med       Date:  2012-04-03       Impact factor: 11.951

5.  Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation.

Authors:  L Nesher; K V I Rolston; D P Shah; J T Tarrand; V Mulanovich; E J Ariza-Heredia; R F Chemaly
Journal:  Transpl Infect Dis       Date:  2014-12-27       Impact factor: 2.228

6.  Socioeconomic Burden of Bloodstream Infections Caused by Carbapenem-Resistant Enterobacteriaceae.

Authors:  Yunying Zhu; Tingting Xiao; Yuan Wang; Kai Yang; Yanzi Zhou; Qixia Luo; Ping Shen; Yonghong Xiao
Journal:  Infect Drug Resist       Date:  2021-12-14       Impact factor: 4.003

Review 7.  Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.

Authors:  Nicola Petrosillo; Maddalena Giannella; Russell Lewis; Pierluigi Viale
Journal:  Expert Rev Anti Infect Ther       Date:  2013-02       Impact factor: 5.091

8.  Clinical Analysis of Bloodstream Infections During Agranulocytosis After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Weijie Cao; Lina Guan; Xiaoning Li; Ran Zhang; Li Li; Suping Zhang; Chong Wang; Xinsheng Xie; Zhongxing Jiang; Dingming Wan; Xiaohui Chi
Journal:  Infect Drug Resist       Date:  2021-01-19       Impact factor: 4.003

9.  Compositional Flux Within the Intestinal Microbiota and Risk for Bloodstream Infection With Gram-negative Bacteria.

Authors:  Igor Stoma; Eric R Littmann; Jonathan U Peled; Sergio Giralt; Marcel R M van den Brink; Eric G Pamer; Ying Taur
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

10.  A prospective observational study of the prevalence and risk factors for colonization by antibiotic resistant bacteria in patients at admission to hospital in Singapore.

Authors:  Barnaby E Young; David C Lye; Prabha Krishnan; Siew Pang Chan; Yee Sin Leo
Journal:  BMC Infect Dis       Date:  2014-06-02       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.